OsteoSee uses its proprietary pEIT-based products to address the enormous unmet need of screening and diagnosing osteoporosis at the point-of-care, and monitoring treatment effect in the home environment.
According to the International Osteoporosis Foundation (IOF), 1 in 3 women and 1 in 5 men are at risk of an osteoporotic fracture. Approximately 9 million osteoporotic fractures occur annually worldwide. According to the World Health Organization (WHO), Osteoporosis is second only to cardiovascular disease as a global healthcare problem and medical studies show a 50-year-old woman has a similar lifetime risk of dying from hip fracture as from breast cancer.
>70% of people at risk of osteoporosis have never been diagnosed or screened. Primary care physicians, where most people get care, are rarely part of the diagnosis and treatment process.
Using OsteoSee’s unique parametric Electrical Impedance Tomography (pEIT), (i) a tabletop system will address the enormous unmet need of screening and diagnosing osteoporosis at the point-of-care, including at primary care physicians’ clinics; and (ii) for the first time, a wristband system connected to a smartphone will enable monitoring of osteoporosis patients undergoing treatment anywhere, including the home.